Adjuvant and neoadjuvant therapy in non-small cell lung cancerBELANI, Chandra P.Seminars in oncology. 2005, Vol 32, Num 2, pp 9-15, issn 0093-7754, 7 p., SUP2Article

Development of docetaxel in advanced non-small-cell lung cancerBELANI, Chandra P; ECKARDT, John.Lung cancer. 2004, Vol 46, pp s3-s11, issn 0169-5002, SUP2Article

Selected Proceedings from the Chemotherapy Foundation Symposium, Innovative Cancer Therapy for TomorrowBELANI, Chandra P.Seminars in oncology. 2005, Vol 32, Num 2, issn 0093-7754, 25 p., SUP2Serial Issue

Docetaxel: Uses and Potential Applications in Early-Stage Non-Small-Cell Lung CancerBELANI, Chandra P.Lung cancer. 2004, Vol 46, issn 0169-5002, 49 p., SUP2Serial Issue

Optimizing chemotherapy for advanced non-small cell lung cancer : focus on docetaxelBELANI, Chandra P.Lung cancer. 2005, Vol 50, pp S3-S8, issn 0169-5002, SUP2Conference Paper

Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancerSCAGLIOTTI, Giorgio V.Seminars in oncology. 2005, Vol 32, Num 2, pp 5-8, issn 0093-7754, 4 p., SUP2Article

Docetaxel in advanced non-small cell lung cancerWAKELEE, Heather; RAMALINGAM, Sakkaraiappan; BELANI, Chandra P et al.Expert review of anticancer therapy. 2005, Vol 5, Num 1, pp 13-24, issn 1473-7140, 12 p.Article

Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326)BELANI, Chandra P; FOSSELLA, Frank.Cancer. 2005, Vol 104, Num 12, pp 2766-2774, issn 0008-543X, 9 p.Article

Quality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapyGRALLA, Richard J; THATCHER, Nick.Lung cancer. 2004, Vol 46, pp s41-s47, issn 0169-5002, SUP2Article

Pemetrexed (akimta) in small cell lung cancerSOCINSKI, Mark A.Seminars in oncology. 2005, Vol 32, Num 2, pp 1-4, issn 0093-7754, 4 p., SUP2Article

Neoadjuvant treatment of early-stage resectable non-small-cell lung cancerBETTICHER, Daniel C; ROSELL, Rafael.Lung cancer. 2004, Vol 46, pp s23-s32, issn 0169-5002, SUP2Article

Basic treatment considerations: chemotherapyRAMALINGAM, Sakkaraiappan; BELANI, Chandra P.Hematology/oncology clinics of North America. 2004, Vol 18, Num 1, pp vii-viii, issn 0889-8588, 19 p.Article

Adjuvant treatment of lung cancer: current status and potential applications of new regimensLE CHEVALIER, Thierry; LYNCH, Thomas.Lung cancer. 2004, Vol 46, pp s33-s39, issn 0169-5002, SUP2Article

Interim analysis of a phase II study of induction weekly paclitaxel/carboplatin regimens followed by maintenance weekly paclitaxel for advanced and metastatic non-small cell lung cancerBELANI, Chandra P.Seminars in oncology. 2001, Vol 28, Num 4, pp 14-16, issn 0093-7754, SUP14Article

Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myelomaBELANI, Chandra P.Seminars in oncology. 2004, Vol 31, Num 6, pp 25-33, issn 0093-7754, 9 p., SUP14Article

Docetaxel in combined-modality treatment of inoperable locally or regionally advanced lung cancerSCAGLIOTTI, Giorgio V; DOUILLARD, J.-Y.Lung cancer. 2004, Vol 46, pp s13-s21, issn 0169-5002, SUP2Article

First-line chemotherapy for NSCLC: an overview of relevant trialsBELANI, Chandra P; LANGER, Corey.Lung cancer. 2002, Vol 38, pp S13-S19, issn 0169-5002, SUP4Article

Lung cancer : Therapeutic options for stage IV and recurrent NSCLCCALVO, Alejandro R; BELANI, Chandra P.Cancer treatment and research. 2001, Vol 105, pp 189-227, issn 0927-3042Article

International Symposium on Thoracic MalignanciesBELANI, Chandra P.Chest. 1998, Vol 113, Num 1, issn 0012-3692, 125 p., SUPConference Proceedings

Maintenance Therapy for Advanced Non-small Cell Lung Cancer: Current Status, Controversies, and Emerging ConsensusOWONIKOKO, Taofeek K; RAMALINGAM, Suresh S; BELANI, Chandra P et al.Clinical cancer research (Print). 2010, Vol 16, Num 9, pp 2496-2504, issn 1078-0432, 9 p.Article

Phase 2 Study of Irinotecan and Paclitaxel in Patients With Recurrent or Refractory Small Cell Lung CancerRAMALINGAM, Suresh S; FOSTER, Judy; GOODING, William et al.Cancer. 2010, Vol 116, Num 5, pp 1344-1349, issn 0008-543X, 6 p.Article

Meaningful survival in lung cancer patientsRAMALINGAM, Sakkaraiappan; BELANI, Chandra P.Seminars in oncology. 2002, Vol 29, Num 1, pp 125-131, issn 0093-7754, SUP4Article

Eastern cooperative oncology group experience with chemotherapy in advanced non-small cell lung cancerBONOMI, P.Chest. 1998, Vol 113, Num 1, pp 13S-16S, issn 0012-3692, SUPConference Paper

New chemotherapeutic agents for the treatment of non-small cell lung cancer : The Japanese ExperienceSAIJO, N.Chest. 1998, Vol 113, Num 1, pp 17S-23S, issn 0012-3692, SUPConference Paper

Surgical Management of Early-Stage Non-small Cell Lung Carcinoma and the Present and Future Roles of Adjuvant Therapy: A Review for the Radiation OncologistMEDFORD-DAVIS, Laura; DECAMP, Malcom; RECHT, Abram et al.International journal of radiation oncology, biology, physics. 2012, Vol 84, Num 5, pp 1048-1057, issn 0360-3016, 10 p.Article